Rhonda Barefield v. HHS - Influenza, Guillain-Barré Syndrome (GBS) (2024)

Rhonda Barefield filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging she suffered Guillain-Barré Syndrome (GBS) as a result of an influenza vaccine administered on December 12, 2018. She also alleged that she suffered residual effects or complications for more than six months.

The case was assigned to the Special Processing Unit. Respondent conceded that Petitioner is entitled to compensation, finding that she satisfied the criteria for a GBS Table injury following an influenza vaccine.

Respondent also agreed that the case was timely filed, the vaccine was received in the United States, and Petitioner met the statutory severity requirement. A ruling on entitlement was issued on February 13, 2023, finding Petitioner entitled to compensation.

Subsequently, on January 9, 2024, Respondent filed a proffer on award of compensation, indicating Petitioner should be awarded a total of $108,347.65. This amount consists of $97,500.00 for pain and suffering and $10,847.65 for past unreimbursable expenses.

Petitioner agreed with the proffered award. The Chief Special Master issued a Decision Awarding Damages on February 13, 2024, awarding Petitioner the lump sum of $108,347.65.